
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CD206/Mannose Receptor/MMR CRISPR/Cas9 KO Plasmid (m) | sc-421707 | 20 µg | $397.00 | |||
CD206/Mannose Receptor/MMR HDR Plasmid (m) | sc-421707-HDR | 20 µg | $445.00 |
Mrc1 encodes CD206 (mannose receptor, MMR), a macrophage and dendritic cell surface C-type lectin that binds mannose-, fucose-, and N-acetylglucosamine–containing glycans to mediate endocytosis and phagocytosis of glycoproteins and microbes. CD206 contributes to pattern recognition, antigen uptake and processing, and modulation of cytokine signaling, linking innate immune sensing to downstream inflammatory and tissue-remodeling programs. It is widely used as a marker of alternatively activated macrophages and participates in pathways shaping macrophage polarization, extracellular matrix turnover, and clearance of glycosylated ligands. Altered Mrc1/CD206 activity and expression have been associated with immune dysregulation in models of infection, fibrosis, metabolic inflammation, and tumor-associated macrophage biology, supporting its relevance in mechanistic immunology studies.
CD206/Mannose Receptor/MMR CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Mrc1 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Mrc1 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, CD206/Mannose Receptor/MMR HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Mrc1 target site.
When co-transfected with CD206/Mannose Receptor/MMR CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Mrc1 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.